Autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011549
A preparation of autologous T lymphocytes (ATL) that have been transduced with the retroviral vector SFG, a Moloney murine leukemia (Mo-MuLV) virus-based vector, encoding a chimeric antigen receptor (CAR) composed of a single chain single-chain variable fragment (scFv) directed against the CD30 antigen (CAR.CD30) and linked, via the spacer human IgG1 immunoglobulin heavy constant region (hinge-CH2CH3 region), to the co-stimulatory domains of CD28 and the zeta chain of the TCR/CD3 complex (CD3-zeta) (CD28zeta), with potential immunostimulating and antineoplastic activities. Upon administration, the autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytes specifically recognize and bind to CD30-expressing tumor cells, resulting in specific T-cell-mediated tumor cell lysis. CD30, a cell surface receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is transiently expressed on activated lymphocytes and is constitutively expressed in hematologic malignancies.
| Identifier | MLC-T-ONC-011549 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ATLCAR.CD30 cells; ATLCAR.CD30-CD28zeta cells; ATL-expressing CD30-CAR-CD28zeta; anti-CD30-CAR/CD28z retroviral vector-transduced autologous T cells; autologous CAR-CD19-CD28-zeta-transduced T lymphocytes; CAR-CD30-28zeta-specific autologous T cells; SFG.CAR.CD30 autologous T lymphocytes |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011549",
"term": "Autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes (ATL) that have been transduced with the retroviral vector SFG, a Moloney murine leukemia (Mo-MuLV) virus-based vector, encoding a chimeric antigen receptor (CAR) composed of a single chain single-chain variable fragment (scFv) directed against the CD30 antigen (CAR.CD30) and linked, via the spacer human IgG1 immunoglobulin heavy constant region (hinge-CH2CH3 region), to the co-stimulatory domains of CD28 and the zeta chain of the TCR/CD3 complex (CD3-zeta) (CD28zeta), with potential immunostimulating and antineoplastic activities. Upon administration, the autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytes specifically recognize and bind to CD30-expressing tumor cells, resulting in specific T-cell-mediated tumor cell lysis. CD30, a cell surface receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is transiently expressed on activated lymphocytes and is constitutively expressed in hematologic malignancies.",
"synonyms": [
"ATLCAR.CD30 cells",
"ATLCAR.CD30-CD28zeta cells",
"ATL-expressing CD30-CAR-CD28zeta",
"anti-CD30-CAR/CD28z retroviral vector-transduced autologous T cells",
"autologous CAR-CD19-CD28-zeta-transduced T lymphocytes",
"CAR-CD30-28zeta-specific autologous T cells",
"SFG.CAR.CD30 autologous T lymphocytes"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes/"
}
Record 2,883 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.